VABYSMO
@vabysmo.com
VABYSMO® (faricimab-svoa) is a prescription medicine given by injection into the eye used to treat adults with wet AMD, DME, and RVO.
VABYSMO's Company Logos
VABYSMO's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#707F2A
Crete
112, 127, 42
71, 50, 33
12, 0, 67, 50
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#441D78
Meteorite
68, 29, 120
266, 61, 29
43, 76, 0, 53
About VABYSMO
VABYSMO™ is a leading brand that offers an innovative and FDA-approved treatment for wet Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME). This treatment is specifically designed to target and block two causes of these conditions - vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2)*, although the full benefit of blocking Ang-2 has not been fully determined.
VABYSMO™, in the form of eye injections, effectively addresses the symptoms and underlying causes of wet AMD and DME. It offers a personalized treatment approach, with dosing intervals ranging from 1 to 4 months, as determined by your doctor.
Safety is a top priority, and VABYSMO™ has undergone rigorous clinical testing. Like any medication, there are potential side effects and precautions to consider. It's important to consult with your healthcare provider and discuss your medical history, including pregnancy or breastfeeding, before starting treatment with VABYSMO™.
Overall, VABYSMO™ is a breakthrough treatment option that provides hope and improved quality of life for those suffering from wet AMD and DME.
*Ang-2=angiopoietin-2; VEGF=vascular endothelial growth factor.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
Related Brands
Tags
Intravitreal injection medicine
VEGF and Ang-2 inhibitor
Wet age-related macular degeneration treatment
Diabetic macular edema treatment
Retinal vein occlusion macular edema treatment
